Everest Boosts Covid Bet With New Licensing Deal Despite Crowded Field
Global agreement for oral anti-viral comes just months after company signed separate similar tie-up for a Covid mRNA vaccine also in development Key Takeaways Everest has signed a global licensing…
RELATED ARTICLES
-
Everest reaches new heights on growing drug sales
1952.HK
- China’s mRNA pioneer Stemirna faces post-Covid reinvention test
-
With healthier finances, Clover Bio shifts to flu and RSV vaccines
2197.HK
- Health Guard plans dual listing to fund HPV vaccine fight
-
Fosun Pharma, CanSino take different paths as Covid lift fade
2196.HK 6185.HK
-
AstraZeneca pays hefty price for Chinese weight-loss drug
AZN.US
-
Missing the Covid boat, Junshi stumbles back to old business
1877.HK 688180.SHG
Discover hidden China stock gems in our weekly newsletter